Population
Dialyzed patients with renal failure
Design
Review
Authors
Loading...
Prioritizes sudden death and HF prevention in dialysis; leaves open targeted therapies for non-atherosclerotic mechanisms.
Cardiovascular risk in dialyzed patients is driven largely by sudden death, heart failure, and cardiomyopathic features rather than just coronary atherosclerosis, highlighting the need to address novel pathomechanisms and alternative dialysis strategies.
Ritz et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: